Cue Biopharma (CUE) Total Non-Current Liabilities (2018 - 2026)
Cue Biopharma's (CUE) quarterly Total Non-Current Liabilities came in at $22.7 million in Q2 2026, up 26.57% quarter-over-quarter from $17.9 million in Q4 2021.
Powered by 
Analysis
Cue Biopharma (CUE) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Cue Biopharma has disclosed Total Non-Current Liabilities across 5 years of filings, most recently posting $22.7 million for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities changed N/A year-over-year to $22.7 million; the TTM figure through Jun 2026 stood at $22.7 million (changed N/A YoY), while the FY2021 annual figure was $17.9 million, down 4.15% from the prior year.
- Total Non-Current Liabilities came in at $22.7 million for Q2 2026 at Cue Biopharma, up from $17.9 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $22.7 million in Q2 2026 to a low of $22.7 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 81.11 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 36.04 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 5.92 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 7.74 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 40.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 3.92 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 12.42 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 378.37 Mn |
| 10 | Cue Biopharma | 179.95 Mn | 162.53 Mn | - | 22.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.67 Mn |
| Dec 31, 2021 | 17.91 Mn |
| Jun 30, 2021 | 16.67 Mn |
| Mar 31, 2021 | 17.72 Mn |
| Dec 31, 2020 | 18.68 Mn |
| Sep 30, 2020 | 17.86 Mn |
| Mar 31, 2020 | 12.28 Mn |
| Dec 31, 2019 | 13.00 Mn |
| Sep 30, 2019 | 13.00 Mn |
| Jun 30, 2019 | 15.06 Mn |
| Mar 31, 2019 | 15.52 Mn |
| Dec 31, 2018 | 6.22 Mn |
| Sep 30, 2018 | 4.59 Mn |
| Jun 30, 2018 | 2.96 Mn |